Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.78962059 |
2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.77239110 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.54598551 |
4 | negative regulation of cell killing (GO:0031342) | 6.54598551 |
5 | regulation of gamma-delta T cell activation (GO:0046643) | 6.24624594 |
6 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.99715201 |
7 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.74976679 |
8 | positive thymic T cell selection (GO:0045059) | 5.71525300 |
9 | negative T cell selection (GO:0043383) | 5.59027718 |
10 | negative thymic T cell selection (GO:0045060) | 5.50343797 |
11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.38789856 |
12 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.12603481 |
13 | interferon-gamma production (GO:0032609) | 5.01469172 |
14 | positive T cell selection (GO:0043368) | 4.99836838 |
15 | positive regulation of isotype switching (GO:0045830) | 4.85194740 |
16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.75384120 |
17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.72602248 |
18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.72602248 |
19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.71665048 |
20 | positive regulation of B cell mediated immunity (GO:0002714) | 4.52217896 |
21 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.52217896 |
22 | thymic T cell selection (GO:0045061) | 4.51366246 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.46199238 |
24 | positive regulation of humoral immune response (GO:0002922) | 4.44400108 |
25 | response to interleukin-15 (GO:0070672) | 4.41800189 |
26 | neutrophil activation involved in immune response (GO:0002283) | 4.38852268 |
27 | T cell migration (GO:0072678) | 4.38108461 |
28 | detection of other organism (GO:0098543) | 4.36770923 |
29 | cellular extravasation (GO:0045123) | 4.29494803 |
30 | positive regulation of DNA recombination (GO:0045911) | 4.26074145 |
31 | NIK/NF-kappaB signaling (GO:0038061) | 4.25849948 |
32 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.21868054 |
33 | T cell selection (GO:0045058) | 4.21010572 |
34 | macrophage activation involved in immune response (GO:0002281) | 4.20284636 |
35 | detection of bacterium (GO:0016045) | 4.14749152 |
36 | leukocyte aggregation (GO:0070486) | 4.11963946 |
37 | cellular response to interleukin-15 (GO:0071350) | 4.11437449 |
38 | myeloid dendritic cell differentiation (GO:0043011) | 4.05385540 |
39 | negative regulation of interleukin-12 production (GO:0032695) | 4.02872795 |
40 | myeloid dendritic cell activation (GO:0001773) | 4.00673896 |
41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.99540103 |
42 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.99429073 |
43 | regulation of T cell tolerance induction (GO:0002664) | 3.99208873 |
44 | tolerance induction (GO:0002507) | 3.96211230 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94933487 |
46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91391816 |
47 | endothelial cell chemotaxis (GO:0035767) | 3.90521912 |
48 | response to peptidoglycan (GO:0032494) | 3.88036414 |
49 | B cell receptor signaling pathway (GO:0050853) | 3.81783623 |
50 | positive regulation of interleukin-2 production (GO:0032743) | 3.78040486 |
51 | detection of external biotic stimulus (GO:0098581) | 3.73885462 |
52 | neutrophil activation (GO:0042119) | 3.73207609 |
53 | immunoglobulin mediated immune response (GO:0016064) | 3.72273346 |
54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.71249409 |
55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.70627425 |
56 | activated T cell proliferation (GO:0050798) | 3.70302132 |
57 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.67650685 |
58 | detection of molecule of bacterial origin (GO:0032490) | 3.67288129 |
59 | regulation of isotype switching (GO:0045191) | 3.64019992 |
60 | regulation of regulatory T cell differentiation (GO:0045589) | 3.63228631 |
61 | regulation of B cell mediated immunity (GO:0002712) | 3.62615007 |
62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62066449 |
63 | T cell receptor signaling pathway (GO:0050852) | 3.55436479 |
64 | regulation of immunoglobulin secretion (GO:0051023) | 3.54645764 |
65 | respiratory burst (GO:0045730) | 3.54518107 |
66 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.54077635 |
67 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.54077635 |
68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52028864 |
69 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.50724322 |
70 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.50724322 |
71 | positive regulation of immunoglobulin production (GO:0002639) | 3.48653130 |
72 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.44657843 |
73 | microglial cell activation (GO:0001774) | 3.44169959 |
74 | regulation of B cell differentiation (GO:0045577) | 3.43137423 |
75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41995987 |
76 | response to host immune response (GO:0052572) | 3.41995987 |
77 | granulocyte activation (GO:0036230) | 3.40031024 |
78 | regulation of chronic inflammatory response (GO:0002676) | 3.40026716 |
79 | myeloid cell activation involved in immune response (GO:0002275) | 3.38390017 |
80 | positive regulation of T cell cytokine production (GO:0002726) | 3.35127359 |
81 | detection of biotic stimulus (GO:0009595) | 3.34535906 |
82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.32649460 |
83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32528979 |
84 | response to muramyl dipeptide (GO:0032495) | 3.32288110 |
85 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.30266985 |
86 | positive regulation of tolerance induction (GO:0002645) | 3.29486932 |
87 | regulation of immunoglobulin production (GO:0002637) | 3.29038323 |
88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28742944 |
89 | T cell costimulation (GO:0031295) | 3.28524804 |
90 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.28342014 |
91 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.28342014 |
92 | neutrophil mediated immunity (GO:0002446) | 3.27119845 |
93 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.26038748 |
94 | positive regulation of B cell differentiation (GO:0045579) | 3.23139412 |
95 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.22065623 |
96 | lymphocyte costimulation (GO:0031294) | 3.21818545 |
97 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.20800846 |
98 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.20071541 |
99 | response to type I interferon (GO:0034340) | 3.18771382 |
100 | macrophage activation (GO:0042116) | 3.18144680 |
101 | cellular response to type I interferon (GO:0071357) | 3.16070496 |
102 | type I interferon signaling pathway (GO:0060337) | 3.16070496 |
103 | response to host (GO:0075136) | 3.15373984 |
104 | response to host defenses (GO:0052200) | 3.15373984 |
105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15373984 |
106 | positive regulation of cell killing (GO:0031343) | 3.14886711 |
107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.14731522 |
108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12905571 |
109 | natural killer cell activation (GO:0030101) | 3.12474303 |
110 | regulation of cell killing (GO:0031341) | 3.11222168 |
111 | defense response to protozoan (GO:0042832) | 3.10755389 |
112 | germinal center formation (GO:0002467) | 3.10458821 |
113 | regulation of response to interferon-gamma (GO:0060330) | 3.08841355 |
114 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08593424 |
115 | positive regulation of granulocyte differentiation (GO:0030854) | 3.07474524 |
116 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06373180 |
117 | T cell proliferation (GO:0042098) | 3.05978979 |
118 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05443798 |
119 | leukocyte cell-cell adhesion (GO:0007159) | 3.04640916 |
120 | positive regulation of interleukin-12 production (GO:0032735) | 3.04446132 |
121 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.03814282 |
122 | regulation of interleukin-2 production (GO:0032663) | 3.03676057 |
123 | regulation of mast cell degranulation (GO:0043304) | 3.01693367 |
124 | leukocyte degranulation (GO:0043299) | 3.01316520 |
125 | mast cell activation (GO:0045576) | 3.01024100 |
126 | regulation of tolerance induction (GO:0002643) | 3.00402830 |
127 | B cell mediated immunity (GO:0019724) | 3.00017954 |
128 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97038132 |
129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95703941 |
130 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.94744603 |
131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.94681238 |
132 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.94065285 |
133 | lymphocyte migration (GO:0072676) | 2.93797986 |
134 | response to protozoan (GO:0001562) | 2.93617237 |
135 | positive regulation of T cell chemotaxis (GO:0010820) | 2.93581322 |
136 | regulation of T cell chemotaxis (GO:0010819) | 2.93581322 |
137 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.92182026 |
138 | negative regulation of innate immune response (GO:0045824) | 2.91183663 |
139 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90618795 |
140 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90618795 |
141 | modulation by symbiont of host immune response (GO:0052553) | 2.90618795 |
142 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90618795 |
143 | modulation by symbiont of host defense response (GO:0052031) | 2.90618795 |
144 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90618795 |
145 | negative regulation of adaptive immune response (GO:0002820) | 2.89302712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.67925538 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.83463425 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.60974451 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.08275456 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.99759279 |
6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.98054818 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.96980466 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84087120 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.50963057 |
10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.38943081 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.38889475 |
12 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.27507482 |
13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.25217332 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.20611875 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 3.16428985 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16412401 |
17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08521703 |
18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98107832 |
19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.89331848 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.83275252 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70345517 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 2.58676488 |
23 | MYB_26560356_Chip-Seq_TH1_Human | 2.49984111 |
24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.44240809 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29707983 |
26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.13126712 |
27 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.06865660 |
28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.05204725 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.94661808 |
30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93340023 |
31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93145966 |
32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91860891 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89102211 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88483269 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88366449 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83987909 |
37 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83251270 |
38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.82834486 |
39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82080509 |
40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81643760 |
41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75079307 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70362847 |
43 | MAF_26560356_Chip-Seq_TH2_Human | 1.65204057 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59500954 |
45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52497321 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49253934 |
47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49075926 |
48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48507566 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47415451 |
50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46220897 |
51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37406363 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37137640 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33394010 |
54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26789224 |
55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26598560 |
56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24948333 |
57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23769971 |
58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22394273 |
59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17601024 |
60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16283106 |
61 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13894167 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12434435 |
63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11880993 |
64 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10693438 |
65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09482036 |
66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07717478 |
67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07245897 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05705764 |
69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04487379 |
70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02829604 |
71 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01620809 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99251278 |
73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98698611 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97714774 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97560438 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96671586 |
77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93533587 |
78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93250486 |
79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92279333 |
80 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91807720 |
81 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90256055 |
82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90250770 |
83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89656034 |
84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87996996 |
85 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.87677716 |
86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86239853 |
87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84967287 |
88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84902397 |
89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84203204 |
90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84151402 |
91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82344291 |
92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80250437 |
93 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.79825390 |
94 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.79509630 |
95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78931228 |
96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76882311 |
97 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.73480421 |
98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.70990071 |
99 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.69383985 |
100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69319196 |
101 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67764280 |
102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65633614 |
103 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64588677 |
104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63557350 |
105 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.62164814 |
106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61975187 |
107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.58743865 |
108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57508985 |
109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.57020734 |
110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.56298922 |
111 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.55833629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 4.15352253 |
2 | MP0001835_abnormal_antigen_presentation | 4.09677588 |
3 | MP0005671_abnormal_response_to | 4.02358951 |
4 | MP0006082_CNS_inflammation | 3.62437237 |
5 | MP0000685_abnormal_immune_system | 3.54244404 |
6 | MP0003436_decreased_susceptibility_to | 3.49294827 |
7 | MP0005000_abnormal_immune_tolerance | 3.22414031 |
8 | MP0001800_abnormal_humoral_immune | 3.18159217 |
9 | MP0009785_altered_susceptibility_to | 3.09485944 |
10 | MP0001790_abnormal_immune_system | 2.98350884 |
11 | MP0005387_immune_system_phenotype | 2.98350884 |
12 | MP0002723_abnormal_immune_serum | 2.85298163 |
13 | MP0002452_abnormal_antigen_presenting | 2.76255873 |
14 | MP0002405_respiratory_system_inflammati | 2.74914513 |
15 | MP0003303_peritoneal_inflammation | 2.71663967 |
16 | MP0002420_abnormal_adaptive_immunity | 2.65384051 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.64783553 |
18 | MP0001819_abnormal_immune_cell | 2.64107293 |
19 | MP0004510_myositis | 2.61935243 |
20 | MP0005025_abnormal_response_to | 2.57121668 |
21 | MP0003300_gastrointestinal_ulcer | 2.45960052 |
22 | MP0002419_abnormal_innate_immunity | 2.45148986 |
23 | MP0003724_increased_susceptibility_to | 2.40066092 |
24 | MP0009333_abnormal_splenocyte_physiolog | 2.39888083 |
25 | MP0002398_abnormal_bone_marrow | 2.39696129 |
26 | MP0001853_heart_inflammation | 2.32144827 |
27 | MP0002166_altered_tumor_susceptibility | 2.26527042 |
28 | MP0000716_abnormal_immune_system | 2.18467973 |
29 | MP0010155_abnormal_intestine_physiology | 2.03597027 |
30 | MP0002006_tumorigenesis | 2.02716558 |
31 | MP0000689_abnormal_spleen_morphology | 1.99406700 |
32 | MP0004947_skin_inflammation | 1.98591854 |
33 | MP0001873_stomach_inflammation | 1.93197066 |
34 | MP0005464_abnormal_platelet_physiology | 1.92538470 |
35 | MP0002722_abnormal_immune_system | 1.91316620 |
36 | MP0000703_abnormal_thymus_morphology | 1.90570942 |
37 | MP0003866_abnormal_defecation | 1.87346681 |
38 | MP0002396_abnormal_hematopoietic_system | 1.87042474 |
39 | MP0001845_abnormal_inflammatory_respons | 1.83705138 |
40 | MP0002429_abnormal_blood_cell | 1.77126187 |
41 | MP0008260_abnormal_autophagy | 1.73581269 |
42 | MP0001533_abnormal_skeleton_physiology | 1.72079045 |
43 | MP0004808_abnormal_hematopoietic_stem | 1.68716882 |
44 | MP0000465_gastrointestinal_hemorrhage | 1.60116034 |
45 | MP0002933_joint_inflammation | 1.46319982 |
46 | MP0000858_altered_metastatic_potential | 1.42601802 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.40926343 |
48 | MP0001851_eye_inflammation | 1.36674602 |
49 | MP0002998_abnormal_bone_remodeling | 1.33972458 |
50 | MP0008469_abnormal_protein_level | 1.32400539 |
51 | MP0005310_abnormal_salivary_gland | 1.31980167 |
52 | MP0005451_abnormal_body_composition | 1.29503585 |
53 | MP0003172_abnormal_lysosome_physiology | 1.24761868 |
54 | MP0003448_altered_tumor_morphology | 1.21503391 |
55 | MP0003045_fibrosis | 1.17124200 |
56 | MP0008057_abnormal_DNA_replication | 1.16213779 |
57 | MP0000604_amyloidosis | 1.07946042 |
58 | MP0002132_abnormal_respiratory_system | 1.05646936 |
59 | MP0005397_hematopoietic_system_phenotyp | 1.05031334 |
60 | MP0001545_abnormal_hematopoietic_system | 1.05031334 |
61 | MP0009278_abnormal_bone_marrow | 1.02724474 |
62 | MP0005166_decreased_susceptibility_to | 1.02606860 |
63 | MP0003191_abnormal_cellular_cholesterol | 1.00568871 |
64 | MP0005058_abnormal_lysosome_morphology | 0.99515615 |
65 | MP0009764_decreased_sensitivity_to | 0.98207122 |
66 | MP0005164_abnormal_response_to | 0.96349382 |
67 | MP0000490_abnormal_crypts_of | 0.92828471 |
68 | MP0003075_altered_response_to | 0.87798336 |
69 | MP0010307_abnormal_tumor_latency | 0.86916743 |
70 | MP0002019_abnormal_tumor_incidence | 0.82266762 |
71 | MP0003656_abnormal_erythrocyte_physiolo | 0.81035318 |
72 | MP0005390_skeleton_phenotype | 0.80037286 |
73 | MP0008004_abnormal_stomach_pH | 0.78557654 |
74 | MP0008961_abnormal_basal_metabolism | 0.78353634 |
75 | MP0008007_abnormal_cellular_replicative | 0.78317001 |
76 | MP0005423_abnormal_somatic_nervous | 0.76574220 |
77 | MP0003795_abnormal_bone_structure | 0.73195534 |
78 | MP0002277_abnormal_respiratory_mucosa | 0.72783896 |
79 | MP0010352_gastrointestinal_tract_polyps | 0.71893223 |
80 | MP0000015_abnormal_ear_pigmentation | 0.71657835 |
81 | MP0009763_increased_sensitivity_to | 0.70262344 |
82 | MP0005076_abnormal_cell_differentiation | 0.70199260 |
83 | MP0001986_abnormal_taste_sensitivity | 0.70192391 |
84 | MP0004130_abnormal_muscle_cell | 0.69790078 |
85 | MP0005023_abnormal_wound_healing | 0.67816805 |
86 | MP0000249_abnormal_blood_vessel | 0.66895543 |
87 | MP0000609_abnormal_liver_physiology | 0.64921626 |
88 | MP0003453_abnormal_keratinocyte_physiol | 0.62648319 |
89 | MP0002136_abnormal_kidney_physiology | 0.61125382 |
90 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59452000 |
91 | MP0000343_altered_response_to | 0.58276029 |
92 | MP0002254_reproductive_system_inflammat | 0.57259514 |
93 | MP0005075_abnormal_melanosome_morpholog | 0.55550012 |
94 | MP0008874_decreased_physiological_sensi | 0.54752647 |
95 | MP0002009_preneoplasia | 0.53829229 |
96 | MP0003183_abnormal_peptide_metabolism | 0.53798709 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.52150978 |
98 | MP0003077_abnormal_cell_cycle | 0.52128327 |
99 | MP0002928_abnormal_bile_duct | 0.52008785 |
100 | MP0004782_abnormal_surfactant_physiolog | 0.51518616 |
101 | MP0004484_altered_response_of | 0.50773745 |
102 | MP0000569_abnormal_digit_pigmentation | 0.50773597 |
103 | MP0008873_increased_physiological_sensi | 0.49575113 |
104 | MP0003690_abnormal_glial_cell | 0.48900024 |
105 | MP0009840_abnormal_foam_cell | 0.47995367 |
106 | MP0002693_abnormal_pancreas_physiology | 0.46563446 |
107 | MP0004883_abnormal_blood_vessel | 0.46463269 |
108 | MP0001663_abnormal_digestive_system | 0.46279628 |
109 | MP0005381_digestive/alimentary_phenotyp | 0.45846184 |
110 | MP0003828_pulmonary_edema | 0.45242411 |
111 | MP0004381_abnormal_hair_follicle | 0.44792848 |
112 | MP0003091_abnormal_cell_migration | 0.43936771 |
113 | MP0001881_abnormal_mammary_gland | 0.42988419 |
114 | MP0005376_homeostasis/metabolism_phenot | 0.40121771 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 7.05219393 |
2 | Eczematoid dermatitis (HP:0000976) | 5.70903329 |
3 | T lymphocytopenia (HP:0005403) | 5.61222700 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.51900918 |
5 | Abnormality of T cell number (HP:0011839) | 5.48719710 |
6 | Recurrent fungal infections (HP:0002841) | 4.44406495 |
7 | Recurrent abscess formation (HP:0002722) | 4.40487827 |
8 | Abnormality of T cells (HP:0002843) | 4.29180168 |
9 | Myositis (HP:0100614) | 4.09832896 |
10 | Severe combined immunodeficiency (HP:0004430) | 4.07935871 |
11 | Recurrent viral infections (HP:0004429) | 4.06476766 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 4.04527141 |
13 | Chronic diarrhea (HP:0002028) | 3.99458201 |
14 | Nasal polyposis (HP:0100582) | 3.99099699 |
15 | Recurrent bacterial skin infections (HP:0005406) | 3.92234771 |
16 | Increased IgM level (HP:0003496) | 3.89307025 |
17 | Combined immunodeficiency (HP:0005387) | 3.79518289 |
18 | Optic neuritis (HP:0100653) | 3.68439379 |
19 | Retrobulbar optic neuritis (HP:0100654) | 3.68439379 |
20 | Recurrent bronchitis (HP:0002837) | 3.65355623 |
21 | Chronic otitis media (HP:0000389) | 3.49412903 |
22 | Panhypogammaglobulinemia (HP:0003139) | 3.48992504 |
23 | IgG deficiency (HP:0004315) | 3.48861093 |
24 | IgM deficiency (HP:0002850) | 3.48304904 |
25 | Systemic lupus erythematosus (HP:0002725) | 3.48152597 |
26 | Orchitis (HP:0100796) | 3.47796829 |
27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46609560 |
28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46609560 |
29 | Abnormality of the nasal mucosa (HP:0000433) | 3.33132420 |
30 | Vasculitis (HP:0002633) | 3.29997474 |
31 | Gastrointestinal infarctions (HP:0005244) | 3.23040944 |
32 | Leukocytosis (HP:0001974) | 3.21532147 |
33 | Pulmonary infiltrates (HP:0002113) | 3.19871689 |
34 | Autoimmune thrombocytopenia (HP:0001973) | 3.18914988 |
35 | Arterial thrombosis (HP:0004420) | 3.17820444 |
36 | IgA deficiency (HP:0002720) | 3.16388336 |
37 | Abnormality of eosinophils (HP:0001879) | 3.15603526 |
38 | Pustule (HP:0200039) | 3.14923319 |
39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11085060 |
40 | Recurrent skin infections (HP:0001581) | 3.10298362 |
41 | Abnormality of T cell physiology (HP:0011840) | 3.08510747 |
42 | Urticaria (HP:0001025) | 3.06428727 |
43 | Prolonged bleeding time (HP:0003010) | 3.06373338 |
44 | Eosinophilia (HP:0001880) | 2.96691619 |
45 | Thyroiditis (HP:0100646) | 2.94404081 |
46 | Thrombocytosis (HP:0001894) | 2.89462918 |
47 | Joint swelling (HP:0001386) | 2.81591297 |
48 | Meningitis (HP:0001287) | 2.80398001 |
49 | Obstructive lung disease (HP:0006536) | 2.79883265 |
50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.79883265 |
51 | Hypochromic anemia (HP:0001931) | 2.79066479 |
52 | Lymphopenia (HP:0001888) | 2.77344427 |
53 | Episodic fever (HP:0001954) | 2.77208724 |
54 | Abnormality of the fingertips (HP:0001211) | 2.76420805 |
55 | Hypochromic microcytic anemia (HP:0004840) | 2.75861538 |
56 | Gingivitis (HP:0000230) | 2.74077663 |
57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72934864 |
58 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.71485884 |
59 | Increased density of long bones (HP:0006392) | 2.71315375 |
60 | Hemoptysis (HP:0002105) | 2.70294341 |
61 | Abnormality of B cell number (HP:0010975) | 2.69010141 |
62 | B lymphocytopenia (HP:0010976) | 2.69010141 |
63 | Inflammation of the large intestine (HP:0002037) | 2.66659300 |
64 | Anorexia (HP:0002039) | 2.64891522 |
65 | Spontaneous hematomas (HP:0007420) | 2.64656597 |
66 | Glomerulonephritis (HP:0000099) | 2.61728104 |
67 | Gangrene (HP:0100758) | 2.56359166 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.52708215 |
69 | Keratoconjunctivitis sicca (HP:0001097) | 2.51085974 |
70 | Hypergammaglobulinemia (HP:0010702) | 2.50815793 |
71 | Granulocytopenia (HP:0001913) | 2.49982844 |
72 | Persistence of primary teeth (HP:0006335) | 2.44010493 |
73 | Abnormality of the pleura (HP:0002103) | 2.42856486 |
74 | Chest pain (HP:0100749) | 2.42433129 |
75 | Lymphoma (HP:0002665) | 2.42225116 |
76 | Colitis (HP:0002583) | 2.42085888 |
77 | Peritonitis (HP:0002586) | 2.39221520 |
78 | Arterial tortuosity (HP:0005116) | 2.38507929 |
79 | Periodontitis (HP:0000704) | 2.37271931 |
80 | Sepsis (HP:0100806) | 2.36915395 |
81 | Agammaglobulinemia (HP:0004432) | 2.35981772 |
82 | Abnormality of the prostate (HP:0008775) | 2.34841217 |
83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.31989682 |
84 | Amaurosis fugax (HP:0100576) | 2.31614990 |
85 | Recurrent sinusitis (HP:0011108) | 2.31259775 |
86 | Keratoconjunctivitis (HP:0001096) | 2.30571848 |
87 | Papilloma (HP:0012740) | 2.29599665 |
88 | Verrucae (HP:0200043) | 2.29599665 |
89 | Epistaxis (HP:0000421) | 2.29461312 |
90 | Abnormality of macrophages (HP:0004311) | 2.29244377 |
91 | Increased IgE level (HP:0003212) | 2.24335401 |
92 | Glomerulopathy (HP:0100820) | 2.24110851 |
93 | Encephalitis (HP:0002383) | 2.23262473 |
94 | Aortic aneurysm (HP:0004942) | 2.21881931 |
95 | Microcytic anemia (HP:0001935) | 2.21136009 |
96 | Slow saccadic eye movements (HP:0000514) | 2.21098716 |
97 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19332912 |
98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19332912 |
99 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19332912 |
100 | Stomach cancer (HP:0012126) | 2.19057104 |
101 | Autoimmune hemolytic anemia (HP:0001890) | 2.18474352 |
102 | Viral hepatitis (HP:0006562) | 2.18015695 |
103 | Fatigue (HP:0012378) | 2.15998869 |
104 | Keratitis (HP:0000491) | 2.14636180 |
105 | Gastrointestinal stroma tumor (HP:0100723) | 2.12777252 |
106 | Acute hepatic failure (HP:0006554) | 2.12515224 |
107 | Petechiae (HP:0000967) | 2.10785648 |
108 | Cellulitis (HP:0100658) | 2.09589967 |
109 | Abnormality of the peritoneum (HP:0002585) | 2.09511096 |
110 | Hematochezia (HP:0002573) | 2.09131017 |
111 | Myocardial infarction (HP:0001658) | 2.08423880 |
112 | Spondylolisthesis (HP:0003302) | 2.06344522 |
113 | Amyloidosis (HP:0011034) | 2.04923162 |
114 | Gingival bleeding (HP:0000225) | 2.02958672 |
115 | Vascular tortuosity (HP:0004948) | 2.01494590 |
116 | Skin ulcer (HP:0200042) | 2.00940832 |
117 | Bronchitis (HP:0012387) | 1.99904728 |
118 | Pulmonary embolism (HP:0002204) | 1.99124277 |
119 | Basal ganglia calcification (HP:0002135) | 1.97880483 |
120 | Hepatosplenomegaly (HP:0001433) | 1.97491224 |
121 | Emphysema (HP:0002097) | 1.96855636 |
122 | Osteomyelitis (HP:0002754) | 1.96808046 |
123 | Skin rash (HP:0000988) | 1.96648191 |
124 | Abnormality of the endocardium (HP:0004306) | 1.95938190 |
125 | Interstitial pulmonary disease (HP:0006530) | 1.94355949 |
126 | Vertigo (HP:0002321) | 1.93335368 |
127 | Restrictive lung disease (HP:0002091) | 1.93151558 |
128 | Papilledema (HP:0001085) | 1.92322665 |
129 | Polyneuropathy (HP:0001271) | 1.90064861 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.55099836 |
2 | TXK | 5.25737248 |
3 | MAP3K14 | 3.46309687 |
4 | ITK | 3.17859747 |
5 | JAK3 | 3.08817569 |
6 | ZAP70 | 3.00521099 |
7 | TGFBR2 | 2.91557397 |
8 | TYK2 | 2.87411761 |
9 | IKBKE | 2.45803524 |
10 | STK10 | 2.41628758 |
11 | IKBKB | 2.31369109 |
12 | PRPF4B | 2.28927816 |
13 | TBK1 | 2.25873608 |
14 | TEC | 1.96649846 |
15 | CSK | 1.96064080 |
16 | TNK2 | 1.94294816 |
17 | JAK1 | 1.92221287 |
18 | IRAK4 | 1.89466394 |
19 | CHUK | 1.85423341 |
20 | FGFR4 | 1.84489474 |
21 | LCK | 1.63157156 |
22 | BTK | 1.58887146 |
23 | HCK | 1.56196675 |
24 | NLK | 1.53034204 |
25 | TSSK6 | 1.52004940 |
26 | PIM2 | 1.47588978 |
27 | BLK | 1.45372722 |
28 | FGFR3 | 1.41638299 |
29 | IRAK3 | 1.37523523 |
30 | MAP3K10 | 1.37395033 |
31 | SYK | 1.36712481 |
32 | PIM1 | 1.33851065 |
33 | MAP2K3 | 1.31991441 |
34 | GRK6 | 1.27887705 |
35 | MAP3K13 | 1.27215047 |
36 | RPS6KA4 | 1.24857869 |
37 | KIT | 1.23064520 |
38 | MAP3K1 | 1.22927971 |
39 | EEF2K | 1.20070492 |
40 | CSF1R | 1.19649137 |
41 | FGR | 1.19351088 |
42 | EPHB1 | 1.10999666 |
43 | RIPK4 | 1.08748709 |
44 | MARK3 | 1.07941974 |
45 | IRAK2 | 1.04497191 |
46 | MST4 | 1.04088330 |
47 | MAPK15 | 1.02772272 |
48 | JAK2 | 1.01901381 |
49 | CDK12 | 1.00304332 |
50 | GRK7 | 0.94498251 |
51 | LYN | 0.92914766 |
52 | CLK1 | 0.91082071 |
53 | KSR2 | 0.88051086 |
54 | YES1 | 0.85598437 |
55 | CAMKK2 | 0.85575319 |
56 | MATK | 0.83950807 |
57 | PIK3CG | 0.83100059 |
58 | MARK2 | 0.82696751 |
59 | RPS6KA5 | 0.81524043 |
60 | EPHA3 | 0.81489388 |
61 | MAP3K11 | 0.78397311 |
62 | TESK2 | 0.77875356 |
63 | PRKCQ | 0.75510472 |
64 | TAOK1 | 0.74320057 |
65 | PRKD2 | 0.73111173 |
66 | MAP3K3 | 0.72241857 |
67 | MELK | 0.71550719 |
68 | CAMKK1 | 0.71547752 |
69 | FES | 0.70349865 |
70 | SIK2 | 0.66943913 |
71 | NME2 | 0.65633788 |
72 | MAP3K6 | 0.65025223 |
73 | IRAK1 | 0.62686283 |
74 | MAPK7 | 0.59595467 |
75 | FYN | 0.59316824 |
76 | SIK3 | 0.58448469 |
77 | ERN1 | 0.57933115 |
78 | PRKCH | 0.57832943 |
79 | NEK9 | 0.56204532 |
80 | MAP3K7 | 0.54211432 |
81 | MAP3K2 | 0.53268313 |
82 | LRRK2 | 0.53003846 |
83 | CDK19 | 0.51706979 |
84 | DYRK1B | 0.51365044 |
85 | ALK | 0.50729978 |
86 | RPS6KA1 | 0.48923345 |
87 | PDPK1 | 0.48720602 |
88 | CDK9 | 0.47092210 |
89 | SMG1 | 0.46950848 |
90 | RPS6KC1 | 0.46623327 |
91 | RPS6KL1 | 0.46623327 |
92 | PDK1 | 0.46536935 |
93 | CDC42BPA | 0.45457328 |
94 | RAF1 | 0.44896486 |
95 | BRD4 | 0.44790102 |
96 | MAPKAPK2 | 0.44198956 |
97 | SGK3 | 0.43788161 |
98 | MAP2K2 | 0.41711920 |
99 | STK11 | 0.40572394 |
100 | IGF1R | 0.38852749 |
101 | SGK2 | 0.38248997 |
102 | PDGFRB | 0.37926051 |
103 | INSR | 0.37894279 |
104 | MAP2K6 | 0.37891040 |
105 | PTK2B | 0.36989092 |
106 | RET | 0.36935429 |
107 | CDK4 | 0.35827375 |
108 | TAOK3 | 0.34478682 |
109 | MAPK12 | 0.34405891 |
110 | MAPK11 | 0.34115147 |
111 | EIF2AK2 | 0.33138448 |
112 | PTK6 | 0.33124470 |
113 | GSK3A | 0.32693345 |
114 | EGFR | 0.32402367 |
115 | PKN2 | 0.31957538 |
116 | TGFBR1 | 0.31421638 |
117 | ABL1 | 0.30934248 |
118 | BMPR2 | 0.30702137 |
119 | MAP3K8 | 0.30422840 |
120 | RPS6KA6 | 0.29709728 |
121 | HIPK2 | 0.27900701 |
122 | FLT3 | 0.26488754 |
123 | TRIB3 | 0.25671234 |
124 | TAOK2 | 0.24992415 |
125 | PAK2 | 0.24426264 |
126 | MAP3K5 | 0.23956096 |
127 | MAPK4 | 0.21972941 |
128 | STK4 | 0.21476066 |
129 | CDK6 | 0.21129231 |
130 | MAPK3 | 0.21118633 |
131 | TRPM7 | 0.20510382 |
132 | PASK | 0.19167446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.44253644 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.39119697 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.27157289 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22502891 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.04209871 |
6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.90745073 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66403890 |
8 | Measles_Homo sapiens_hsa05162 | 2.57285630 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55983892 |
10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45944446 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.21803198 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.18464865 |
13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13363985 |
14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99082355 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94984826 |
16 | Asthma_Homo sapiens_hsa05310 | 1.93895408 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91916829 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88676531 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83616058 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81068821 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79412708 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.78720668 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.75271250 |
24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.74623755 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73064272 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.72729301 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71460322 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.68679799 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.52580522 |
30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47385479 |
31 | Pertussis_Homo sapiens_hsa05133 | 1.47288727 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.46687843 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37921348 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37777933 |
35 | Malaria_Homo sapiens_hsa05144 | 1.37140971 |
36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.33766306 |
37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30247744 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29116312 |
39 | Tuberculosis_Homo sapiens_hsa05152 | 1.26688400 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.20620121 |
41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14897969 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13308225 |
43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12411198 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10515389 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.08000677 |
46 | Shigellosis_Homo sapiens_hsa05131 | 1.01269235 |
47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98897044 |
48 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96794728 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96118013 |
50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95126642 |
51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91848915 |
52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90249558 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87086630 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.86284591 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82466729 |
56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78556281 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76625261 |
58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71990606 |
59 | Prion diseases_Homo sapiens_hsa05020 | 0.70077253 |
60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68803517 |
61 | Platelet activation_Homo sapiens_hsa04611 | 0.68755909 |
62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63828093 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63561203 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63144027 |
65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61243424 |
66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60784766 |
67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59494869 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57907593 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53962066 |
70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53366903 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53318631 |
72 | Lysosome_Homo sapiens_hsa04142 | 0.50967313 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50695130 |
74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48491669 |
75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46876812 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45047129 |
77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43868940 |
78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42444001 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41996855 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.41876461 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41810136 |
82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39636215 |
83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38520661 |
84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37967865 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37516561 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37075639 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34852900 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.32139984 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32054913 |
90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30593489 |
91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30017371 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29068997 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28963871 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.28848103 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27745675 |
96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27484640 |
97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27100422 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.25218675 |
99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25121643 |
100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24382854 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24088999 |
102 | Spliceosome_Homo sapiens_hsa03040 | 0.23304242 |
103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21284160 |
104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21016178 |
105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20352574 |
106 | RNA degradation_Homo sapiens_hsa03018 | 0.18005147 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17793190 |
108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17277555 |
109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16331133 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15694058 |
111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15421216 |
112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14774573 |
113 | Phagosome_Homo sapiens_hsa04145 | 0.14427637 |
114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.12491781 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11420326 |
116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.10905573 |